GLP-3s are more potent than GLP-1s, and the side effects may be stronger. You can experience nausea, diarrhea, or constipation. That’s why it’s important to take them under medical supervision, ...
Eli Lilly ( LLY 2.05%) delivered a gain worthy of a technology growth stock last year. The pharma giant's shares soared 39%, ...
Bunnie XO shares her harrowing experience with an experimental weight-loss drug, describing severe depression and suicidal ...
The State Oil Fund of the Republic of Azerbaijan has signed long-term strategic partnerships with Brookfield Asset Management ...
A ‘triple-strength’ weight-loss jab has just been approved by NHS watchdog Medicines and Healthcare products Regulatory ...
The Traitors star Stephen Libby is hoping to make it to the end of the his BBC show and bag the huge cash prize - and he is ...
Both Skyrizi and its cousin Rinvoq have landed in the annual top three, in varying positions, since 2022. That was once again the case in 2025, when Skyrizi retained its place at the top and Rinvoq ...
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced development progress for RHB-102 (Bekinda®) in multiple GI indications, ...
The TV star was last seen on TV screens with the latest season of Prime Video's Clarkson's Farm ...
Aboitiz InfraCapital owns and operates the Mactan-Cebu International Airport. Aboitiz Equity Ventures (AEV)—controlled by tycoon Sabin Aboitiz and his family—is raising 13.7 billion pesos ($233 ...
'This strategic partnership enhances the industrial potential and the value of the portfolio projects, reinforces Eni's ambition to be a leading global player in the CCS sector and paves the way for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results